"Guarantee Assessment in Skin Prevention Adapted to Real Life With a Connected Device After a Spinal Cord Injury."
NCT ID: NCT05403606
Last Updated: 2022-06-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
242 participants
INTERVENTIONAL
2022-06-30
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Internet Self-Management for People With Intermittent Urinary Catheters
NCT02168465
Positioning in Wheelchair Bound Patients
NCT05653089
Injured Spinal Cord Pressure Evaluation
NCT02721615
Clinical Evaluation of Instrumented Wheel as Biomedical Device Quantifying the Displacement Efficiency
NCT01935687
EMG and SSEP Device (EPAD® 2.0) for Intraoperative Monitoring of Patient Undergoing Spinal Nerve Spine Surgery
NCT03848377
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental Group (GASPARD®)
Spinal cord injured patient with the connected electronic seat pressure measurement device (GASPARD®), a traditional follow-up and having received therapeutic education at the end of the treatment
GASPARD®
Spinal cord injured patient with the connected electronic seat pressure measurement device (GASPARD®), a traditional follow-up and having received therapeutic education at the end of the treatment
Control group:
Spinal cord injured patient with traditional follow-up with therapeutic education at discharge from initial care
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GASPARD®
Spinal cord injured patient with the connected electronic seat pressure measurement device (GASPARD®), a traditional follow-up and having received therapeutic education at the end of the treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Motor level \< C6
* Complete or incomplete injury (AIS A, B and C impairment scale)
* Primarily using a manual wheelchair (with or without electric propulsion assistance) as a means of mobility
* At least 18 years of age
* At any time after the occurrence of the spinal cord injury
* Patients discharged from the center, with a first post-injury rehabilitation completed
* Having participated in a specific therapeutic patient education on pressure ulcer prevention
* No pelvic pressure sores under medical or surgical treatment at the time of inclusion
* No aorto-iliac arterial disease that may promote pelvic ischemia (arterial Doppler \<6 months)
* Patient using a cushion approved by the HAS
* Patients with a smartphone
Exclusion Criteria
* Motor level of the lesion \> or = C6
* Incomplete motor lesion (AIS D and E)
* Patients who walk as their primary mode of ambulation
* Use of an electric wheelchair
* Minors
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nantes University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
MARC LE FORT
Role: PRINCIPAL_INVESTIGATOR
Nantes University Hospital
GAELLE AUDAT
Role: PRINCIPAL_INVESTIGATOR
CRRF l'Arche
RECH CELIA
Role: PRINCIPAL_INVESTIGATOR
Raymond Poincaré Hospital
KERDRAON Jacques
Role: PRINCIPAL_INVESTIGATOR
CRRF Kerpape
GELIS ANTHONY
Role: PRINCIPAL_INVESTIGATOR
Centre Mutualiste Neurologique Propora
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC21_0044
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.